165 related articles for article (PubMed ID: 20177374)
21. Constitutive activity of the serotonin2C receptor inhibits in vivo dopamine release in the rat striatum and nucleus accumbens.
De Deurwaerdère P; Navailles S; Berg KA; Clarke WP; Spampinato U
J Neurosci; 2004 Mar; 24(13):3235-41. PubMed ID: 15056702
[TBL] [Abstract][Full Text] [Related]
22. Potential learning and memory disruptors and enhancers in a simple, 1-day operant task in mice.
Sanku RKK; John JS; Salkovitz M; Ilies MA; Walker EA
Behav Pharmacol; 2018 Sep; 29(6):482-492. PubMed ID: 29570113
[TBL] [Abstract][Full Text] [Related]
23. Stimulation of medial prefrontal cortex serotonin 2C (5-HT(2C)) receptors attenuates cocaine-seeking behavior.
Pentkowski NS; Duke FD; Weber SM; Pockros LA; Teer AP; Hamilton EC; Thiel KJ; Neisewander JL
Neuropsychopharmacology; 2010 Sep; 35(10):2037-48. PubMed ID: 20520599
[TBL] [Abstract][Full Text] [Related]
24. Meta-chlorophenylpiperazine induced changes in locomotor activity are mediated by 5-HT1 as well as 5-HT2C receptors in mice.
Gleason SD; Shannon HE
Eur J Pharmacol; 1998 Jan; 341(2-3):135-8. PubMed ID: 9543230
[TBL] [Abstract][Full Text] [Related]
25. The 5-HT1A receptor agonist flesinoxan shares discriminative stimulus properties with some 5-HT2 receptor antagonists.
Herremans AH; van der Heyden JA; van Drimmelen M; Olivier B
Pharmacol Biochem Behav; 1999 Oct; 64(2):389-95. PubMed ID: 10515319
[TBL] [Abstract][Full Text] [Related]
26. Involvement of 5-HT2C receptors in mediating the discriminative stimulus properties of m-chlorophenylpiperazine (mCPP).
Callahan PM; Cunningham KA
Eur J Pharmacol; 1994 May; 257(1-2):27-38. PubMed ID: 8082704
[TBL] [Abstract][Full Text] [Related]
27. The quipazine- and TFMPP-increased conditioned avoidance response in rats: role of 5HT1C/5-HT2 receptors.
Alhaider AA; Ageel AM; Ginawi OT
Neuropharmacology; 1993 Dec; 32(12):1427-32. PubMed ID: 8152532
[TBL] [Abstract][Full Text] [Related]
28. Discriminative stimulus properties of indorenate, a 5-HT1A, 5-HT1B and 5-HT2C agonist: a study in rats.
Sánchez H; Velázquez-Martínez DN
J Psychopharmacol; 2001 Mar; 15(1):29-36. PubMed ID: 11277605
[TBL] [Abstract][Full Text] [Related]
29. Activity of serotonin (5-HT) receptor agonists, partial agonists and antagonists at cloned human 5-HT1A receptors that are negatively coupled to adenylate cyclase in permanently transfected HeLa cells.
Pauwels PJ; Van Gompel P; Leysen JE
Biochem Pharmacol; 1993 Jan; 45(2):375-83. PubMed ID: 8382063
[TBL] [Abstract][Full Text] [Related]
30. LSD but not lisuride disrupts prepulse inhibition in rats by activating the 5-HT(2A) receptor.
Halberstadt AL; Geyer MA
Psychopharmacology (Berl); 2010 Feb; 208(2):179-89. PubMed ID: 19937319
[TBL] [Abstract][Full Text] [Related]
31. Anxiolytic-like actions of BW 723C86 in the rat Vogel conflict test are 5-HT2B receptor mediated.
Kennett GA; Trail B; Bright F
Neuropharmacology; 1998 Dec; 37(12):1603-10. PubMed ID: 9886683
[TBL] [Abstract][Full Text] [Related]
32. Effects of agonists, partial agonists, and antagonists on the regulation of 5-hydroxytryptamine2 receptors in P11 cells.
Ferry RC; Unsworth CD; Molinoff PB
Mol Pharmacol; 1993 May; 43(5):726-33. PubMed ID: 8388988
[TBL] [Abstract][Full Text] [Related]
33. Antagonism of meta-chlorophenylpiperazine-induced inhibition of exploratory activity in an emergence procedure, the open field test, in rats.
Meert TF; Melis W; Aerts N; Clincke G
Behav Pharmacol; 1997 Aug; 8(4):353-63. PubMed ID: 9832994
[TBL] [Abstract][Full Text] [Related]
34. S32212, a novel serotonin type 2C receptor inverse agonist/α2-adrenoceptor antagonist and potential antidepressant: I. A mechanistic characterization.
Millan MJ; Mannoury la Cour C; Chanrion B; Dupuis DS; Di Cara B; Audinot V; Cussac D; Newman-Tancredi A; Kamal M; Boutin JA; Jockers R; Marin P; Bockaert J; Muller O; Dekeyne A; Lavielle G
J Pharmacol Exp Ther; 2012 Mar; 340(3):750-64. PubMed ID: 22178752
[TBL] [Abstract][Full Text] [Related]
35. Effects of serotonin agonists on operant behavior in the squirrel monkey: quipazine, MK-212, trifluoromethylphenylpiperazine, and chlorophenylpiperazine.
McKearney JW
Pharmacol Biochem Behav; 1990 Jan; 35(1):181-5. PubMed ID: 2315357
[TBL] [Abstract][Full Text] [Related]
36. Effects of quipazine and m-chlorophenylbiguanide (m-CPBG) on temporal differentiation: evidence for the involvement of 5-HT2A but not 5-HT3 receptors in interval timing behaviour.
Body S; Asgari K; Rickard JF; Zhang Z; Fone KC; Bradshaw CM; Szabadi E
Psychopharmacology (Berl); 2005 Sep; 181(2):289-98. PubMed ID: 15864559
[TBL] [Abstract][Full Text] [Related]
37. Antiobesity-like effects of the 5-HT2C receptor agonist WAY-161503.
Rosenzweig-Lipson S; Zhang J; Mazandarani H; Harrison BL; Sabb A; Sabalski J; Stack G; Welmaker G; Barrett JE; Dunlop J
Brain Res; 2006 Feb; 1073-1074():240-51. PubMed ID: 16430874
[TBL] [Abstract][Full Text] [Related]
38. Constitutively active 5-hydroxytryptamine2C receptors reveal novel inverse agonist activity of receptor ligands.
Barker EL; Westphal RS; Schmidt D; Sanders-Bush E
J Biol Chem; 1994 Apr; 269(16):11687-90. PubMed ID: 7909313
[TBL] [Abstract][Full Text] [Related]
39. Effects of serotonin 5-HT1B receptor ligands on the cocaine- and food-maintained self-administration in rats.
Przegaliński E; Gołda A; Frankowska M; Zaniewska M; Filip M
Eur J Pharmacol; 2007 Mar; 559(2-3):165-72. PubMed ID: 17291490
[TBL] [Abstract][Full Text] [Related]
40. Behavioral characterization of serotonergic activation in the flatworm Planaria.
Farrell MS; Gilmore K; Raffa RB; Walker EA
Behav Pharmacol; 2008 May; 19(3):177-82. PubMed ID: 18469535
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
